Elección de antiagregantes plaquetarios en SCA sin EST. ¿Deberíamos cambiar nuestra práctica?

9alejandromartinez
Alejandro Martínez
2012-06-07

More articles by this author

Avances técnicos en implantación de válvula aórtica percutánea.

Cristiam Arancibia - Alejandro D'Aiello2012-06-07

Relid: Evaluación retrospectiva de dosis a cristalino.

Ariel Durán.2012-06-07

Procesos de validación en el reuso del material.

Simone de Souza Fantin2012-06-07

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....